Burke William P. Mr.

SEC source: 0001179110-22-000267 · edgar.xml · nonDerivative · entry 1

Burke William P. Mr. · CIK 0001682069 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,405

F1 · shares: Restricted stock units ("RSUs") that vest upon the earlier of (i) the next annual meeting of the company or (ii) one year from the grant date.

SEC source: 0000899243-21-034143 · doc4.xml · derivative · entry 5

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,435 shares

Expires 2024-06-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

SEC source: 0000899243-21-034143 · doc4.xml · derivative · entry 4

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,232 shares

Expires 2023-10-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

SEC source: 0000899243-21-034143 · doc4.xml · nonDerivative · entry 3

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,291

F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F2 · price: Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $60.06 to $60.88, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F3 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0000899243-21-034143 · doc4.xml · nonDerivative · entry 2

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,958

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0000899243-21-034143 · doc4.xml · nonDerivative · entry 1

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,523

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0001127602-21-021568 · form4.xml · nonDerivative · entry 1

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,291

F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F2 · balance_after: This number includes unvested restricted stock units previously reported.

SEC source: 0001127602-21-020050 · form4.xml · nonDerivative · entry 1

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,584

F1 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0001127602-21-019522 · form4.xml · nonDerivative · entry 1

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,774

F1 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0001127602-21-017677 · form4.xml · nonDerivative · entry 3

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,185

F5 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2019 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F5 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2019 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F3 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0001127602-21-017677 · form4.xml · derivative · entry 4

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,933

Underlying: Common Stock · 17,933 shares

Expires 2028-05-18

F6 · derivative.exercise_date: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.

SEC source: 0001127602-21-017677 · form4.xml · nonDerivative · entry 2

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,423

F4 · kind: The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 50% beginning on the first anniversary of the date of grant.

F4 · shares: The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 50% beginning on the first anniversary of the date of grant.

F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.

F3 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0001127602-21-017677 · form4.xml · nonDerivative · entry 1

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,746

F1 · kind: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant.

F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant.

F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.

F3 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0001127602-21-017257 · form4.xml · nonDerivative · entry 1

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,118

F1 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0001127602-20-027619 · form4.xml · nonDerivative · entry 1

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,337

F1 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0001127602-20-019790 · form4.xml · nonDerivative · entry 6

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,498

F5 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.97 to $92.24, inclusive.

F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

SEC source: 0001127602-20-019790 · form4.xml · nonDerivative · entry 5

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,707

F5 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.95 to $91.95, inclusive.

F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

SEC source: 0001127602-20-019790 · form4.xml · nonDerivative · entry 4

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,853

F5 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.94 to $90.94, inclusive. The reporting person undertakes to provide to Haemonetics Corporation ("Haemonetics"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (6) through (8) to this Form 4.

F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

SEC source: 0001127602-20-019790 · form4.xml · nonDerivative · entry 3

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,112

F4 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the PSUs reported above on June 12, 2020. This sale is mandated by the Issuer's election under its 2005 Long-Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F4 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the PSUs reported above on June 12, 2020. This sale is mandated by the Issuer's election under its 2005 Long-Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

SEC source: 0001127602-20-019790 · form4.xml · nonDerivative · entry 2

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,832

F3 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

SEC source: 0001127602-20-019790 · form4.xml · nonDerivative · entry 1

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,029

F1 · kind: Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on June 6, 2017, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from June 6, 2017 to June 5, 2020, as certified by the Compensation Committee of the Board of Directors on June 12, 2020.

F1 · shares: Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on June 6, 2017, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from June 6, 2017 to June 5, 2020, as certified by the Compensation Committee of the Board of Directors on June 12, 2020.

F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

SEC source: 0001127602-20-019376 · form4.xml · nonDerivative · entry 1

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,695

F1 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0001127602-20-017235 · form4.xml · derivative · entry 3

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,639

Underlying: Common Stock · 10,639 shares

Expires 2027-05-18

F5 · derivative.exercise_date: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.

SEC source: 0001127602-20-017235 · form4.xml · nonDerivative · entry 2

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,334

F3 · kind: The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant.

F3 · shares: The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant.

F4 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.

F2 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0001127602-20-017235 · form4.xml · nonDerivative · entry 1

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,190

F1 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0000899243-19-026127 · doc4.xml · nonDerivative · entry 5

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,411

F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F2 · balance_after: This number includes unvested restricted stock units previously reported.

SEC source: 0000899243-19-026127 · doc4.xml · nonDerivative · entry 4

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,859

F5 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: This number includes unvested restricted stock units previously reported.

SEC source: 0000899243-19-026127 · doc4.xml · derivative · entry 6

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,232

Underlying: Common Stock · 11,231 shares

Expires 2023-10-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F6 · derivative.exercise_date: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.

SEC source: 0000899243-19-026127 · doc4.xml · nonDerivative · entry 3

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,014

F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging form $120.38 to $120.97, inclusive.

F2 · balance_after: This number includes unvested restricted stock units previously reported.

SEC source: 0000899243-19-026127 · doc4.xml · nonDerivative · entry 2

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,340

F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.38 to $120.35, inclusive. the reporting person undertakes to provide to Haemonetics Corporation ("Haemonetics"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) and (4) to this Form 4.

F2 · balance_after: This number includes unvested restricted stock units previously reported.

SEC source: 0000899243-19-026127 · doc4.xml · nonDerivative · entry 1

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,245

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F2 · balance_after: This number includes unvested restricted stock units previously reported.

SEC source: 0001127602-19-030383 · form4.xml · nonDerivative · entry 4

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,014

F3 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.22 to $124.97, inclusive.

F2 · balance_after: This number includes unvested restricted stock units previously reported.

SEC source: 0001127602-19-030383 · form4.xml · nonDerivative · entry 3

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,462

F3 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.22 to $124.21, inclusive.

F2 · balance_after: This number includes unvested restricted stock units previously reported.

SEC source: 0001127602-19-030383 · form4.xml · nonDerivative · entry 2

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,818

F3 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.21 to $123.18, inclusive. The reporting person undertakes to provide to Haemonetics Corporation ("Haemonetics"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) through (6) to this Form 4.

F2 · balance_after: This number includes unvested restricted stock units previously reported.

SEC source: 0001127602-19-030383 · form4.xml · nonDerivative · entry 1

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,718

F1 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain performance share units previously reported in Table I on October 8, 2019. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain performance share units previously reported in Table I on October 8, 2019. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: This number includes unvested restricted stock units previously reported.

SEC source: 0001127602-19-030268 · form4.xml · nonDerivative · entry 1

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,668

F1 · kind: Represents shares earned from a performance share unit award granted to the reporting person on October 25, 2016, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from October 1, 2016 to September 30, 2019, as certified by the Compensation Committee of the Board of Directors on October 4, 2019.

F2 · balance_after: This number includes unvested restricted stock units previously reported.

SEC source: 0001127602-19-030039 · form4.xml · derivative · entry 7

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,435

Underlying: Common Stock · 5,718 shares

Expires 2024-06-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F8 · derivative.exercise_date: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.

SEC source: 0001127602-19-030039 · form4.xml · nonDerivative · entry 6

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,014

F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.55 to $129.00, inclusive.

F2 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0001127602-19-030039 · form4.xml · nonDerivative · entry 5

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,481

F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.31 to $127.99, inclusive.

F2 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0001127602-19-030039 · form4.xml · nonDerivative · entry 4

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,129

F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.29 to $127.18, inclusive.

F2 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0001127602-19-030039 · form4.xml · nonDerivative · entry 3

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,799

F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.24 to $126.16, inclusive.

F2 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0001127602-19-030039 · form4.xml · nonDerivative · entry 2

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,108

F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.21 to $124.98, inclusive. The reporting person undertakes to provide to Haemonetics Corporation ("Haemonetics"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (7) to this Form 4.

F2 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0001127602-19-030039 · form4.xml · nonDerivative · entry 1

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,178

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F2 · balance_after: This number includes unvested RSUs previously reported.

SEC source: 0001127602-19-021560 · form4.xml · nonDerivative · entry 1

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,460

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: This number includes unvested restricted stock units previously reported.

SEC source: 0001127602-19-021235 · form4.xml · nonDerivative · entry 1

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,650

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: This number includes unvested restricted stock units previously reported.

SEC source: 0001127602-19-018729 · form4.xml · derivative · entry 2

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,684

Underlying: Common Stock · 10,684 shares

Expires 2026-05-14

F4 · derivative.exercise_date: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.

SEC source: 0001127602-19-018729 · form4.xml · nonDerivative · entry 1

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,061

F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2005 Long-Term Incentive Compensation Plan (as amended). The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant.

F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.

F3 · balance_after: This number includes unvested restricted stock units previously reported.

SEC source: 0001127602-18-032653 · form4.xml · derivative · entry 3

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,463

Underlying: Common Stock · 11,232 shares

Expires 2023-10-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F3 · derivative.exercise_date: Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.

SEC source: 0001127602-18-032653 · form4.xml · nonDerivative · entry 2

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,001

F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F2 · balance_after: This number includes unvested restricted stock units previously reported.

SEC source: 0001127602-18-032653 · form4.xml · nonDerivative · entry 1

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,057

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F2 · balance_after: This number includes unvested restricted stock units previously reported.